{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:28:20Z","timestamp":1785878900142,"version":"3.56.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000027","name":"Institute of Cancer Research","doi-asserted-by":"publisher","award":["PLBIO INCa_18469"],"award-info":[{"award-number":["PLBIO INCa_18469"]}],"id":[{"id":"10.13039\/501100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.retram.2023.103409","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T11:35:54Z","timestamp":1694950554000},"page":"103409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)"],"prefix":"10.1016","volume":"71","author":[{"given":"Nathalie","family":"Auger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Douet-Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Quessada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Theisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Lafage-Pochitaloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-9670","authenticated-orcid":false,"given":"Marie-B\u00e9reng\u00e8re","family":"Troadec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0001","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.retram.2023.103409_bib0002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2023.103409_bib0003","first-page":"1569","article-title":"Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions","volume":"9","author":"Hasle","year":"1995","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0004","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1182\/asheducation-2016.1.598","article-title":"Myelodysplastic and myeloproliferative disorders of childhood","volume":"2016","author":"Hasle","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.retram.2023.103409_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.813149","article-title":"Lessons from pediatric MDS: approaches to germline predisposition to hematologic malignancies","volume":"12","author":"Avagyan","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.retram.2023.103409_bib0006","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood-2002-11-3444","article-title":"Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7","volume":"102","author":"Kardos","year":"2003","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.retram.2023.103409_bib0007","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1182\/blood-2010-04-280313","article-title":"Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome","volume":"116","author":"G\u00f6hring","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0008","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/leu.2016.342","article-title":"Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants","volume":"31","author":"Pastor","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103409_bib0009","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-017-01590-5","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","volume":"8","author":"Schwartz","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41375-020-0917-7","article-title":"Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS","volume":"35","author":"Kuendgen","year":"2021","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.retram.2023.103409_bib0011","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.retram.2023.103409_bib0012","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2023.103409_bib0013","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.retram.2023.103409_bib0014","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2023.103409_bib0015","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia After MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0016","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"13","key":"10.1016\/j.retram.2023.103409_bib0017","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0018","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2141.2000.01868.x","article-title":"Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espa\u00f1ol de Citogen\u00e9tica Hematol\u00f3gica","volume":"108","author":"Sol\u00e9","year":"2000","journal-title":"Br J Haematol F\u00e9vr"},{"issue":"10","key":"10.1016\/j.retram.2023.103409_bib0019","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/gcc.22377","article-title":"The 5q deletion size in myeloid malignancies is correlated to additional chromosomal aberrations and to TP53 mutations","volume":"55","author":"Stengel","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.retram.2023.103409_bib0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0021","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/cancers13030481","article-title":"Asian population is more prone to develop high-risk myelodysplastic syndrome, concordantly with their propensity to exhibit high-risk cytogenetic aberrations","volume":"13","author":"Jiang","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0022","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00277-008-0483-y","article-title":"Cytogenetic features in myelodysplastic syndromes","volume":"87","author":"Haase","year":"2008","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.retram.2023.103409_bib0023","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3324\/haematol.2013.094912","article-title":"What lies beyond del(5q) in myelodysplastic syndrome?","volume":"98","author":"Adema","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.retram.2023.103409_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104059","article-title":"Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q","volume":"80","author":"Adema","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.retram.2023.103409_bib0025","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1182\/blood.V99.12.4638","article-title":"Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome","volume":"99","author":"Boultwood","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0026","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/leu.2012.9","article-title":"Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS\/AML patients","volume":"26","author":"Douet-Guilbert","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0027","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood-2007-01-068809","article-title":"Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders","volume":"110","author":"Joslin","year":"2007","journal-title":"Blood"},{"issue":"7176","key":"10.1016\/j.retram.2023.103409_bib0028","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q- syndrome gene by RNA interference screen","volume":"451","author":"Ebert","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2141.2008.07178.x","article-title":"Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes","volume":"142","author":"Pellagatti","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.retram.2023.103409_bib0031","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1182\/blood-2010-12-324715","article-title":"Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q\u2212 syndrome","volume":"118","author":"Kumar","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2023.103409_bib0032","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.20.01659","article-title":"Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes","volume":"39","author":"Bersanelli","year":"2021","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.retram.2023.103409_bib0033","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/gcc.22151","article-title":"Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome","volume":"53","author":"Volkert","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"22","key":"10.1016\/j.retram.2023.103409_bib0034","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1002\/cncr.24575","article-title":"The heterogeneous prognosis of patients with myelodysplastic syndrome (MDS) and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?","volume":"115","author":"Kantarjian","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.leukres.2006.10.023","article-title":"Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes","volume":"31","author":"Olney","year":"2007","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.retram.2023.103409_bib0036","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10147-019-01462-6","article-title":"Genetic abnormalities and pathophysiology of MDS","volume":"24","author":"Hosono","year":"2019","journal-title":"Int J Clin Oncol ao\u00fbt"},{"issue":"9","key":"10.1016\/j.retram.2023.103409_bib0037","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7150\/ijms.12612","article-title":"Genomic copy number variations in the myelodysplastic syndrome and acute myeloid leukemia patients with del(5q) and\/or -7\/del(7q)","volume":"12","author":"Zhang","year":"2015","journal-title":"Int J Med Sci"},{"issue":"26","key":"10.1016\/j.retram.2023.103409_bib0038","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2017-12-822262","article-title":"The enigma of monosomy 7","volume":"131","author":"Inaba","year":"2018","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0039","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/diagnostics12071658","article-title":"Cytogenetic and genetic abnormalities with diagnostic value in myelodysplastic syndromes (MDS): focus on the pre-messenger RNA splicing process","volume":"12","author":"Douet-Guilbert","year":"2022","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.retram.2023.103409_bib0040","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/gcc.22761","article-title":"Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations","volume":"58","author":"Hartmann","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0041","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/leu.2012.347","article-title":"IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10)","volume":"27","author":"Westman","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0042","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjh.15190","article-title":"Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries","volume":"181","author":"D\u00edez-Campelo","year":"2018","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0043","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.retram.2023.103409_bib0044","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1080\/10428194.2019.1585840","article-title":"Comprehensive molecular characterization of myeloid malignancies with 9q deletion","volume":"60","author":"Hartmann","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.leukres.2010.07.018","article-title":"Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features","volume":"35","author":"Wang","year":"2011","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.retram.2023.103409_bib0046","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/leu.2017.180","article-title":"MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations","volume":"31","author":"Stengel","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0047","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/bloodadvances.2021005311","article-title":"The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11","volume":"6","author":"Lafage-Pochitaloff","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.retram.2023.103409_bib0048","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.retram.2023.103409_bib0049","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/gcc.22292","article-title":"Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: results from a German diagnostic study in comparison with an international control group","volume":"54","author":"Braulke","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.retram.2023.103409_bib0050","unstructured":"Mitelman F., Johansson B., Mertens F. Mitelman Database Chromosome Aberrations and Gene Fusions in Cancer [Internet]. 2011 [cit\u00e9 20 avr 2023]. (Eds). available on https:\/\/mitelmandatabase.isb-cgc.org\/."},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0051","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/gcc.21918","article-title":"ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events","volume":"51","author":"Haferlach","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1016\/j.retram.2023.103409_bib0052","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3324\/haematol.2011.061127","article-title":"Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO \u00ab MDS-U \u00bb designation","volume":"97","author":"Hosokawa","year":"2012","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0053","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-4608(85)90089-5","article-title":"Deletion of chromosome band 13q14: a primary event in preleukemia and leukemia","volume":"18","author":"Morgan","year":"1985","journal-title":"Cancer Genet Cytogenet"},{"issue":"12","key":"10.1016\/j.retram.2023.103409_bib0054","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3324\/haematol.2011.061127","article-title":"Comment to \u00ab Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO \u201cMDS-U\u201d designation \u00bb Haematologica","volume":"97","author":"Holbro","year":"2012","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0055","first-page":"470","article-title":"Myelodysplastic\/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group","volume":"35","author":"Kanagal-Shamanna","year":"2022","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0056","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MOH.0000000000000313","article-title":"Implications of molecular genetic diversity in myelodysplastic syndromes","volume":"24","author":"Bejar","year":"2017","journal-title":"Curr Opin Hematol"},{"issue":"21","key":"10.1016\/j.retram.2023.103409_bib0057","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.3390\/cancers13215392","article-title":"TP53 in myelodysplastic syndromes","volume":"13","author":"Jiang","year":"2021","journal-title":"Cancers"},{"issue":"20","key":"10.1016\/j.retram.2023.103409_bib0058","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1158\/1078-0432.CCR-20-2272","article-title":"Acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations - a distinct stem cell disorder","volume":"26","author":"Sill","year":"2020","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0059","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/bloodadvances.2019001101","article-title":"Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes","volume":"4","author":"Montalban-Bravo","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0060","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41375-018-0351-2","article-title":"TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups","volume":"33","author":"Haase","year":"2019","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.retram.2023.103409_bib0061","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.3109\/10428194.2015.1028053","article-title":"Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes","volume":"56","author":"S\u00e1nchez-Castro","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.retram.2023.103409_bib0062","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.12710","article-title":"Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact","volume":"164","author":"Bacher","year":"2014","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.retram.2023.103409_bib0063","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41375-022-01561-w","article-title":"The complex karyotype in hematological malignancies: a comprehensive overview by the francophone group of hematological cytogenetics (GFCH)","volume":"36","author":"Nguyen-Khac","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.retram.2023.103409_bib0064","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07436.x","article-title":"Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome","volume":"143","author":"Douet-Guilbert","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/gcc.23004","article-title":"Comparison of myeloid neoplasms with nonclassic 3q26.2\/MECOM versus classic inv(3)\/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation","volume":"61","author":"Gao","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0066","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1080\/10428194.2020.1737689","article-title":"Prognosis of MECOM (EVI1)-rearranged MDS and AML patients rather depends on accompanying molecular mutations than on blast count","volume":"61","author":"Summerer","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.retram.2023.103409_bib0067","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2217\/fon.15.64","article-title":"3q26\/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review","volume":"11","author":"De Braekeleer","year":"2015","journal-title":"Future Oncol Lond Engl"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0068","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2014-07-591461","article-title":"Mutational spectrum of myeloid malignancies with inv(3)\/t(3;3) reveals a predominant involvement of RAS\/RTK signaling pathways","volume":"125","author":"Gr\u00f6schel","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0069","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccr.2014.02.008","article-title":"A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression","volume":"25","author":"Yamazaki","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","article-title":"A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia","volume":"157","author":"Gr\u00f6schel","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0071","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41467-018-06208-y","article-title":"EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription","volume":"9","author":"Ayoub","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0072","first-page":"1581","article-title":"Myelodysplastic Syndrome: diagnosis and Screening","volume":"12","author":"Tria","year":"2022","journal-title":"Diagn Basel Switz"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0073","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bjh.17473","article-title":"The clinicopathological analysis of organising pneumonia in myelodysplastic syndrome: high frequency in der(1;7)(q10; p10)","volume":"194","author":"Matsunawa","year":"2021","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.retram.2023.103409_bib0074","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/gcc.22760","article-title":"Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes","volume":"58","author":"Ganster","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/gcc.22333","article-title":"Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes","volume":"55","author":"Nomdedeu","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.retram.2023.103409_bib0076","first-page":"1168","article-title":"Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes","volume":"90","author":"Sol\u00e9","year":"2005","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0077","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bjh.12035","article-title":"Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes","volume":"159","author":"Saumell","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0078","first-page":"170","article-title":"Beh\u00e7et's-like syndrome and other dysimmunitary manifestations related to myelodysplastic syndromes with trisomy 8","volume":"42","author":"Wesner","year":"2021","journal-title":"Rev Med"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0079","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2001-12-0188","article-title":"Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8","volume":"100","author":"Nilsson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103409_bib0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.leukres.2017.09.001","article-title":"The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians","volume":"61","author":"Kim","year":"2017","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.retram.2023.103409_bib0081","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjh.15490","article-title":"Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des My\u00e9lodysplasies","volume":"182","author":"Drevon","year":"2018","journal-title":"Br J Haematol"},{"issue":"23","key":"10.1016\/j.retram.2023.103409_bib0082","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"10.1016\/j.retram.2023.103409_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129375","article-title":"Trisomy 8, a cytogenetic abnormality in myelodysplastic syndromes, is constitutional or not?","volume":"10","author":"Saumell","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0084","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/leu.2009.289","article-title":"Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features","volume":"24","author":"Wang","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0085","first-page":"371","article-title":"Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation","volume":"4","author":"Alseraye","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"10.1016\/j.retram.2023.103409_bib0086","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2008-10-182170","article-title":"13: prevalence and clinicopathologic correlates of another potentially lenalidomide-sensitive cytogenetic abnormality","volume":"113","author":"Mesa","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2023.103409_bib0087","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood-2008-04-152678","article-title":"Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13","volume":"113","author":"Fehniger","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0088","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-4608(92)90330-B","article-title":"Myelodysplastic syndrome and trisomy 14q","volume":"64","author":"Tumewu","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.retram.2023.103409_bib0089","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/365318","article-title":"Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression","volume":"2010","author":"Cui","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-4608(93)90146-D","article-title":"Trisomy 14 in hematologic diseases. Another non-random abnormality within myeloid proliferative disorders","volume":"66","author":"Mancini","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0091","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0165-4608(94)90031-0","article-title":"Trisomy 19 as the sole chromosomal anomaly in hematologic neoplasms","volume":"74","author":"Johansson","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0092","article-title":"Rare cytogenetic abnormalities in myelodysplastic syndromes","volume":"7","author":"Bacher","year":"2015","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0093","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"issue":"46","key":"10.1016\/j.retram.2023.103409_bib0094","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1038\/onc.2010.351","article-title":"Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome","volume":"29","author":"De Vita","year":"2010","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.retram.2023.103409_bib0095","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1182\/blood-2009-09-242107","article-title":"Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome","volume":"115","author":"Ng","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2023.103409_bib0096","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood.V96.8.2862","article-title":"High incidence of biallelic point mutations in the Runt domain of the AML1\/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21","volume":"96","author":"Preudhomme","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2023.103409_bib0097","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood-2007-07-102533","article-title":"RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance","volume":"111","author":"Roche-Lestienne","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2023.103409_bib0098","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.5858\/2008-132-1329-LOTYCA","article-title":"Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia\/myelodysplastic syndrome?","volume":"132","author":"Wong","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0099","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I","article-title":"Clinical significance of Y chromosome loss in hematologic disease","volume":"27","author":"Wiktor","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3324\/haematol.2019.240689","article-title":"Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells","volume":"106","author":"Ouseph","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0101","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.leukres.2007.06.004","article-title":"Leukemias associated with Turner syndrome: report of three cases and review of the literature","volume":"32","author":"Manola","year":"2008","journal-title":"Leuk Res"},{"issue":"11","key":"10.1016\/j.retram.2023.103409_bib0102","doi-asserted-by":"crossref","first-page":"E285","DOI":"10.1002\/ajh.25601","article-title":"Isolated isochromosomes i(X)(p10) and idic(X)(q13) are associated with myeloid malignancies and dysplastic features","volume":"94","author":"Penther","year":"2019","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0103","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1365-2141.1995.tb05405.x","article-title":"Isodicentric (X)(q13) in haematological malignancies: presentation of five new cases, application of fluorescence in situ hybridization (FISH) and review of the literature","volume":"91","author":"Dierlamm","year":"1995","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1016\/j.retram.2023.103409_bib0104","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0105","first-page":"463","article-title":"Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia","volume":"8","author":"Gurnari","year":"2018","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.retram.2023.103409_bib0106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-4608(94)00283-H","article-title":"Characterization by chromosome painting of balanced and unbalanced X chromosome translocations in myelodysplastic syndromes","volume":"82","author":"Michaux","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0107","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-4608(89)90085-X","article-title":"Twenty-six patients with hematologic disorders and X chromosome abnormalities. Frequent idic(X)(q13) chromosomes and Xq13 anomalies associated with pathologic ringed sideroblasts","volume":"42","author":"Dewald","year":"1989","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0108","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-4608(02)00764-1","article-title":"Translocation (X;20)(q13.1;q13.3) as a primary chromosomal finding in two patients with myelocytic disorders","volume":"141","author":"Gray","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"issue":"12","key":"10.1016\/j.retram.2023.103409_bib0109","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/sj.leu.2402713","volume":"16","author":"Mauritzson","year":"2002","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.leukres.2009.07.006","article-title":"Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: an International Working Group on MDS Cytogenetics Study","volume":"34","author":"Chun","year":"2010","journal-title":"Leuk Res"},{"issue":"11","key":"10.1016\/j.retram.2023.103409_bib0111","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/gcc.22667","article-title":"Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: detailed analysis of clonal composition, involved abnormalities, and prognostic significance","volume":"57","author":"Schanz","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.retram.2023.103409_bib0112","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","article-title":"TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML","volume":"6","author":"Weinberg","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.retram.2023.103409_bib0113","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/leu.2015.304","article-title":"Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes","volume":"30","author":"Sallman","year":"2016","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.retram.2023.103409_bib0114","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/gcc.22112","article-title":"Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing","volume":"52","author":"Arenillas","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.retram.2023.103409_bib0115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jha2.651","article-title":"Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype","volume":"4","author":"Mallo","year":"2023","journal-title":"eJHaem"},{"issue":"4","key":"10.1016\/j.retram.2023.103409_bib0116","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood-2012-12-471847","article-title":"Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome","volume":"122","author":"Mohamedali","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2023.103409_bib0117","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/leu.2015.110","article-title":"High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)","volume":"29","author":"Mohamedali","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.retram.2023.103409_bib0118","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","article-title":"High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.retram.2023.103409_bib0119","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.26487","article-title":"Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping","volume":"97","author":"Rack","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.retram.2023.103409_bib0120","unstructured":"Auger, N., et al. Guide de bonnes pratiques en cytog\u00e9n\u00e9tique. 2020; available on: http:\/\/www.eaclf.org\/docs\/GBPcyto\/GBPC-ACLF_15122021.pdf."}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:41:29Z","timestamp":1762821689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318623000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":120,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2452318623000338"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103409","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103409"}}